Acrobiosystems Co Ltd
SZSE:301080

Watchlist Manager
Acrobiosystems Co Ltd Logo
Acrobiosystems Co Ltd
SZSE:301080
Watchlist
Price: 42.77 CNY -6.31% Market Closed
Market Cap: 5.1B CNY
Have any thoughts about
Acrobiosystems Co Ltd?
Write Note

Acrobiosystems Co Ltd
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Acrobiosystems Co Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Acrobiosystems Co Ltd
SZSE:301080
EPS (Diluted)
ÂĄ1
CAGR 3-Years
10%
CAGR 5-Years
56%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
EPS (Diluted)
-ÂĄ4
CAGR 3-Years
17%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
EPS (Diluted)
ÂĄ0
CAGR 3-Years
-5%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
EPS (Diluted)
ÂĄ0
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
16%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
EPS (Diluted)
ÂĄ2
CAGR 3-Years
-18%
CAGR 5-Years
16%
CAGR 10-Years
33%
Imeik Technology Development Co Ltd
SZSE:300896
EPS (Diluted)
ÂĄ6
CAGR 3-Years
35%
CAGR 5-Years
52%
CAGR 10-Years
N/A
No Stocks Found

Acrobiosystems Co Ltd
Glance View

Market Cap
5.1B CNY
Industry
Biotechnology

ACROBiosystems Co., Ltd. engages in the development of biomedicine and bio-protein technology. The company is headquartered in Beijing, Beijing and currently employs 397 full-time employees. The company went IPO on 2021-10-18. The firm's main products are recombinant proteins and detection services, as well as kits, antibodies, fillers, culture media and other related products. The firm's main products and services are applied to research and development (R&D) and production links such as early drug discovery and verification, drug screening and optimization, development and optimization of diagnostic reagents, preclinical and clinical trials, drug production process and process control (CMC) of tumors, autoimmune diseases, cardiovascular diseases, infectious diseases and other diseases.

Intrinsic Value
49.48 CNY
Undervaluation 14%
Intrinsic Value
Price

See Also

What is Acrobiosystems Co Ltd's EPS (Diluted)?
EPS (Diluted)
1.3 CNY

Based on the financial report for Dec 31, 2023, Acrobiosystems Co Ltd's EPS (Diluted) amounts to 1.3 CNY.

What is Acrobiosystems Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
56%

Over the last year, the EPS (Diluted) growth was 13%. The average annual EPS (Diluted) growth rates for Acrobiosystems Co Ltd have been 10% over the past three years , 56% over the past five years .

Back to Top